Wall Street researchers just used Claude to design a drug. The experiment has spawned a new investment thesis.

MarketWatch Techen

Wall Street researchers just used Claude to design a drug. The experiment has spawned a new investment thesis.

For years, artificial-intelligence evangelists have boasted about the technology’s capacity to revolutionize drug development and medical research.

This is a short summary published by AI Global Wire. The full article is owned and hosted by MarketWatch Tech — open it there to read it in full.

Read the full story at MarketWatch Tech
  • Anthropic
  • Forskning

Related AI news